Skip to content

Retrograde and Antegrade Enema for Prevention of LARS After LAR: a Randomized Controlled Trial

Retrograde and Antegrade Enema for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06717854
Enrollment
72
Registered
2024-12-05
Start date
2025-03-25
Completion date
2026-12-30
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Anterior Resection Syndrome

Brief summary

The goal of this clinical trial is to learn if enema works to prevent low anterior resection syndrome (LARS) in adults. The main questions it aims to answer are: 1. To describe the level of stoma adaptation before and after the patients received enemas during the stoma period as well as the levels and trends of LARS, bowel function, sleep quality, and quality of life after stoma reduction surgery 2. To compare the effects and advantages and disadvantages of antegrade and retrograde enema, and to investigate whether these two types of enema can provide safe and effective preventive measures for the prevention of LARS, the improvement of bowel function, and the enhancement of sleep and quality of life in rectal cancer patients after low anterior resection. Researchers will compare antegrade enema, retrograde enema, and the standard of care to see if these two types of enema work to prevent LARS. Participants will: 1. Receive either antegrade or retrograde enema or no enema based on the standard of care at 1 month after anterior rectal resection, until the ileostomy reversal. 2. Keep a diary of their symptoms.

Interventions

The enema is administered retrogradely via the anus. The enema commences one month post-operatively for patients with well-healed wounds, absence of stoma-related complications, and no evidence of anastomotic leakage upon digital examination, until ileostomy reversal. the catheter is gently and slowly inserted 7-10 cm through the anus. The initial irrigation volume is set at 500 ml and is gradually increased based on the patient's tolerance, up to a maximum of 1000 ml. 39-41°C warm water is the choice. Enemas are administered twice weekly, with each session limited to a duration of 30 minutes.

The enema is administered through the distal end of the ileocecal stoma, directed towards the anus. The enema commences one month post-operatively for patients with well-healed wounds, absence of stoma-related complications, and no evidence of anastomotic leakage upon digital examination, until ileostomy reversal. Using a disposable catheter, insert it about 20 cm. The initial irrigation volume is set at 500 ml and is gradually increased based on the patient's tolerance, up to a maximum of 1000 ml. 39-41°C warm water is the choice. Enemas are administered twice weekly, with each session limited to a duration of 30 minutes.

Sponsors

Sichuan Cancer Hospital and Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Based on the NCCN guidelines for the pathological diagnosis of rectal cancer, patients are identified as having Primary Rectal Adenocarcinoma. * ≥18 years. * For the first time, anterior rectal dissection combined with prophylactic ileostomy was performed using laparoscopic, robotic, and open techniques. * The patient exhibits normal cognitive and expressive abilities. * Informed consent was obtained for voluntary participation in the study.

Exclusion criteria

* American Society of Anesthesiologists (ASA) Class III or higher. * A combination of other intestinal conditions, including inflammatory bowel disease and Crohn's disease. * Mental disorders and prolonged use of psychotropic medications. * The presence of contraindications to enema administration.

Design outcomes

Primary

MeasureTime frame
low anterior resection syndrome score (LARS score)Pre-discharge, 1 month, 2 months, 3 months, 6 months after ileostomy reversal

Secondary

MeasureTime frameDescription
bowel functionbefore anterior rectal resection; 1 month, 2 months, 3 months, 6 months after stoma reversalMemorial Sloan Kettering Cancer Centre Bowel Function Instrument (MSKCC BFI)
quality of life for rectal cancer patientsbefore anterior rectal resection; 1 month, 2 months, 3 months, 6 months after stoma reversalquality of life will be measured using the EORTC Colorectal Cancer Module QLQ-CR29 (EORTC QLQ-CR29 )
quality of sleepbefore anterior rectal resection, before starting enemas 1 month postoperatively, 2 months, 3-4 months postoperatively; 1 month, 2 months, 3 months, 6 months after stoma reductionPittsburgh Quality Index (PSQI)

Other

MeasureTime frame
A quality of life questionnaire for people with an ostomy (Stoma-QoL)1 month after anterior rectal resection before starting enemas, 2 months and 3-4 months postoperatively
Anal drainage and irritation during ileostomy (self-made)1 month after anterior rectal resection before starting enemas, 2 months and 3-4 months postoperatively
Ostomy Adjustment Inventory-20 (OAI-20)1 month after anterior rectal resection before starting enemas, 2 months and 3-4 months postoperatively

Countries

China

Contacts

Primary ContactHai Hu, M.D.
Hu_hai2019@outlook.com8613540662185

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026